Publication | Closed Access

ACAT inhibitor pactimibe sulfate (CS-505) reduces and stabilizes atherosclerotic lesions by cholesterol-lowering and direct effects in apolipoprotein E-deficient mice

InflammationAtherosclerotic LesionsOxysterolBiochemistryCardiovascular DiseaseMedicineDirect EffectsHyperlipidemiaVascular BiologyApolipoprotein E-deficient MicePharmacologyAtherosclerosisDyslipidemiaOxidative Stress